Table 6.
Model | Type | Tissue sites | Effects | Mechanisms | RF |
---|---|---|---|---|---|
MCAO in rats | In vivo | Ischemic stroke | ↓ mortality rates ↓ t-PA-mediated BBB disruption ↓ hemorrhagic transformation |
Scavenge peroxynitrite ↓ MMP-9 expression and activity ↓ Peroxynitrite-mediated MMP-9 activation |
[147] |
STZ injection aggravated the brain damage induced by MCAO surgery OGD/REP-induced P12 cells | In vivo In vitro |
Cerebral I/R injury | ↓ blood glucose, neurological deficit, and infarct volume ↓ ROS production and Drp-1 expression ↓ mitochondrial fission ↑ mitofusin-2 (MFN2) generation ↑ Drp-1 Ser637 phosphorylation ↑ mitochondrial membrane potential |
↓ cell apoptosis ↑ mitophagy Regulating mitochondrial functions in an AMPK-dependent manner |
[151] |
Global cerebral I/R in gerbil OGD-induced SH-SY5Y cells |
In vivo In vitro |
Ischemia-induced memory impairment | ↑ learning and memory impairment ↓ intracellular calcium concentration ↓ phosphorylation level of CaMKII ↓ caspase-3 and Bax expression ↑ Bcl-2 expression |
↓ phosphorylation level of CaMKII ↓ hippocampal neuronal apoptosis |
[149] |
Hypoxic-ischemic encephalopathy in rats | In vivo | Hypoxic-ischemic injury | ↓ cerebral infarct volume ↓ neuronal loss ↓ apoptosis ↑ p-AKT and glutamate transporter 1 expression |
↑ glutamate transporter 1 via the PI3K/AKT signaling pathway | [150] |
MCAO in rats | In vivo | Cerebral ischemic injury | ↓ neurological deficits ↓ infarct volume ↑ NeuN, GFAP, and progesterone receptor expression |
↑ progesterone and adrenocorticotropic hormone expression | [152] |
MCAO/R in rats OGD/R-induced primary astrocytes |
In vivo In vitro |
Acute ischemic stroke | ↓ SDH level ↓ glutamine synthetase loss ↓ ROS production |
↓ ROS production ↓ excitotoxicity ↑ glutamate disposal ↓ oxidative stress |
[148] |
RF: reference; other abbreviations as shown in the literature. (↓): downregulation or inhibition; (↑): upregulation or activation.